Michael H. Mulroy, Director: Lineage Cell Therapeutics LCTX Buy · Filed 24/11/25

Trade details

Type: Insider buy
Amount: $22,800
Shares · price: 40,000 sh · $0.57 a share
Held after: 298,555 sh
Stock: Lineage Cell Therapeutics LCTX
Person: Michael H. MulroyDirector
Trade date: 24/11/22
Filed: 24/11/25
Days to filing: 3 days

First buy since 2023

Insiders buying this week: 4 insiders
Holding change: +15.5%

Lineage Cell Therapeutics trades, last 26 weeks

What else happened in Lineage Cell Therapeutics around then

Filed or reported within 30 days of the trade day · 24/10/23~24/12/22

Michael H. Mulroy's recent trades

No other trades yet.